Bayer

As diagnostic tools improve, it’s becoming increasingly clear that transthyretin amyloid cardiomyopathy (ATTR-CM) is an underdiagnosed cause of heart failure. Dr. Ariane de Hoog, Head of Pharma Dynamic Shared Ownership Communications at Bayer, shares her deeply personal story about her mother’s struggle to get diagnosed with ATTR-CM, and how this experience shaped Ariane´s commitment to Bayer´s mission, #HealthForAll, #HungerForNone. A lack of awareness around ATTR-CM contributes to its underdiagnosis as a cause of heart failure. 🔗 Watch the full video of Ariane’s journey, along with the personal stories of other #TeamBayer employees. Check the comments below for the link! 👇 #InspiredByYou

Which skills will future-proof you? Heike Prinz, Member of the Board of Management of Bayer AG, Chief Talent Officer & Labor Director, shares her thoughts on the most important career skills. From resilience to teamwork: Her insights show you how to take control of your own development and actively shape it. Swipe through the slides to get Heike's career advice! #TeamBayer #BayerCareer #BeBayer

Much of the impact of stroke remains unseen, with the fear of recurrence and the challenges of recovery often hidden from view. #TeamBayer partnered with talented artists to transform the experiences of six stroke survivors into powerful works of art. Their stories highlight that stroke is not merely a single event ‒ the effects can persist long after, and the concern for recurrence is a continuous reality. At Bayer, we are committed to amplifying these voices. By sharing survivor stories, we aim to raise awareness of stroke recurrence and underscore the critical need for improved secondary stroke prevention. Together, we are making #TheInvisibleMadeVisible Secondary stroke deserves another look ✌️ Learn more about Stroke Survivor Stories: Link in the comments below👇 #NoToTwo #StrokeActionNow

Ruth R. Shah's advice shows that careers don’t have to follow a fixed plan. For her, it was less about rigid roadmaps and more about building meaningful, sustainable relationships that opened new doors. Her story reminds us that: • Having a plan is great, but it’s not the only way forward. • Strong, authentic connections can accelerate your growth. • Networking is most powerful when it’s built on mutual value. What’s the most valuable connection you’ve made in your career? Share your story in the comments!

✨ Wir glauben daran, dass Kunst die Menschen zusammenbringt – und dafür brauchen wir mutige Programme. Manchmal braucht es auch nur einen Moment, um zu spüren, was sie bewirken kann. Zum Beispiel, wenn im Mai die österreichische Ikone Conchita Wurst die Bühne des Deutschen Nationaltheaters in Weimar betreten wird. Mit dem stARTfestival schaffen wir Räume, in denen Fragen entstehen können. Es verbindet, öffnet Perspektiven und regt zum Dialog an – über Grenzen, Sparten und Lebenswelten hinweg. Von April bis Juni 2026 geht das stARTfestival von Bayer in eine neue Runde. An sechs Standorten in Deutschland – darunter Leverkusen, Monheim, Berlin, Wuppertal und Weimar – treffen Klassik auf Clubkultur, Kontinente aufeinander und Geschichten auf offene Ohren. 🎭 Das Programm? So vielfältig wie die Kunst selbst: von audiovisuellen Uraufführungen über Tanzproduktionen bis hin zu einem Geburtstagskonzert eines der ältesten Ensembles unserer Kulturgeschichte. 🎟️ Der Vorverkauf läuft! 👉 Mehr Infos & Tickets: www.startfestival.de #stARTfestival #KunstVerbindet #TeamBayer #KulturellesEngagement

🌎 Two sides of the globe, united by one goal: developing cell and gene therapies for patients, with no time to lose. 📍 Berkeley, CA U.S.A.: Our bustling biotech campus is developing and launching advanced medicines that target illnesses at their source. 📍Berlin, Germany: We broke ground on a brand-new Gene and Cell Therapy Center, teaming up with Charité. 📍San Sebastián, Spain: Our partners AskBio and Viralgen’s manufacturing sites give innovators the best way to scale through AAV-based gene therapy. 🌍 We’re investing in innovation all around the globe to help advance life-changing cell and gene therapies for patients with no time to lose.

In a video interview with German newspaper BILD, our CEO Bill Anderson gives an update on Bayer's transformation and how we harness new technologies like AI to overcome key challenges in medicine and agriculture. https://lnkd.in/eUUsiz2F

Menopause is a chapter in life that many women enter quietly, yet it’s a life-changing transition that deserves open conversations. A global survey of women found that only 20 percent of women feel well-informed about menopause. Symptoms like hot flashes, sleep disturbances, mood swings, and memory lapses are often endured in silence, leaving many women feeling lost or invisible. That's why discussions between women and healthcare providers are crucial to finding meaningful solutions for symptoms. At #TeamBayer, we are committed to supporting women on this journey. Together, we can change the narrative – from silence and stigma to openness and support. It is time to amplify the many voices and experiences, ensuring every woman can feel seen, heard, and empowered. #MenopauseAwareness #WomensHealth #YouAreNotAlone

Since 2019 Leaps by Bayer, the company‘s venture capital unit, has been supporting agri-tech startup Apollo Agriculture in scaling their business. Over the years, Apollo expanded from Kenya to Zambia and has entered into a partnership with Bayer | Crop Science to support farmers across #Kenya and #Zambia to gain access to innovations like Bayer’s drought-resistant corn seeds, to help them grow enough food, income, and opportunity to sustain thriving communities. Learn more about Apollo’s business below: